Guiding You to Higher Ground
Strategic, commercial, and capital advisory for pharma services businesses and the investors who support them.
// ABOUT FREEDOM
Where Experience Shapes What's Next
Freedom Bioscience Partners works with founder-led businesses and VC or PE-backed organizations at critical moments of growth and transition across the life science services ecosystem.
Grounded in more than 30-years of experience serving as an operator, advisor, and investor in pharma services, we’ve lived the realities of building and scaling science-forward businesses. We know where growth stalls, where valuation gets discounted, and where capital conversations go sideways.
It's at these pivotal moments where clarity and trusted guidance matter most. That's where we focus our work.
// WHO WE WORK WITH
Where We Have Built, Advised, & Invested
Freedom brings three decades of operating, advisory, and investment experience across the pharma services ecosystem and the firms who invest in them.
Focus Areas
-
Drug Substance / Drug Product
-
Biologics and Small Molecules
-
Formulation Dev / Particle Engineering
-
Analytical (CMC / Bioanalysis)
-
Discovery Enablement
CROs & CDMOs
Focus Areas
-
Production Inputs / Functional Excipients
-
Advanced Materials / Biomaterials
-
Research Reagents and Materials
-
In-Vitro Research Tools
-
Synthetic Biology Platforms
Functional Materials / Life Science Tools
Focus Areas
-
Board Advisory
-
Diligence ; Techno-Commericial
-
Thesis Development
-
Portfolio Strategy
-
Deal Sourcing
VC & PE Investors
// OUR SERVICES
How We Create Value
We focus our work across 4 core areas of engagement:
Commercial & Market Advisory
Advising leadership teams on translating strong technical capabilities into focused positioning, scalable commercial strategy, and sustainable growth.
-
Commercial leadership support, leveraging strong industry connections
-
Go-to-market & revenue strategy aligned with market demand
-
Market and competitive intelligence to inform positioning & growth decisions
Designed for companies running strong science-led businesses and seeking sharper commercial direction & accelerated revenue growth.
-
Capital & Transaction Readiness
Enhance value creation by preparing businesses for future capital raises, strategic investment, M&A, and exit; Elevating how the business is viewed by future investors.
-
Capital raise & exit preparation - Grounded in value creation
-
Growth Roadmapping - Positioning for future organic / inorganic growth
-
De-risking across commercial & operational areas
For teams approaching capital or transaction-related inflection points.
-
Investment Advisory
Advising private equity and venture capital firms with strategic and tactical, board-level judgment applied to investment decisions and portfolio peformance.
-
Board-level and portfolio advisory
-
Deal sourcing and thesis development
-
Commercial and market diligence
-
Growth strategy, add-on acquisitions, and portfolio prioritization
For investors who value deep industry connections and market insight alongside financial & operational analysis.
-
Thought Leadership & Market Perspective
Providing a clear, current view of how the pharma services market is evolving and what it means for operators and investors.
-
Interpreting market shifts across CROs, CDMOs, and life sciences services
-
Shaping industry dialogue through publications, conferences, panels, and media
-
Grounding industry conversations with real-world operating and investment experience
Designed to provide clarity and direction above the noise.
-
// WHY FREEDOM
Grounded in Experience, Focused on Value Creation.
Freedom Bioscience Partners brings a market-tested perspective built over decades inside CROs, CDMOs, and Life Science Materials/Tools businesses. Our work reflects firsthand experience operating at the same inflection points our clients face — when growth accelerates, ownership shifts, and the consequences of decisions begin to compound.
We’ve been in the room for these transitions, helping leaders move with clarity when the stakes rise and the margin for error narrows. Along the way, we’ve built deep, trusted relationships across owner-founder businesses, corporate strategics, and the investor universe. Simply stated, we use our experience and network with precision and purpose.
Clients work with Freedom for clarity, judgment, and credibility — Especially when the decisions are complex and the margin for error is small.
Brian Scanlan
Managing Partner
Freedom Bioscience Partners
// FEATURED PUBLICATIONS
.jpg)
Strategic & Board Advisory
High-level guidance to help founders, executives, and boards evaluate options, align priorities, and navigate complex decisions with confidence.
Growth & Transaction Readiness
Support through growth inflection points, capital raises, and M&A — Helping leadership teams prepare, position, and move forward deliberately.
Investor & Private Equity Advisory
Independent perspective and market insight for private equity firms across diligence, deal origination, and portfolio company support.
Industry Thought Leadership
Contribution to industry dialogue through publications, conferences, panels, podcasts, and media — Bringing experienced, real-world perspective to conversations shaping the biotech services landscape.
// HOW WE CREATE VALUE
Commercial & Market Advisory
Advising leadership teams on how to translate strong technical capabilities into focused positioning, scalable commercial strategy, and sustainable growth.
-
Go-to-market and revenue strategy aligned with market demand
-
Commercial leadership support, including sales and partnerships
-
Market and competitive insight to inform positioning and growth decisions
Designed for companies running strong science-led businesses and seeking sharper commercial direction.
Capital & Transaction Readiness
Preparing businesses for capital raises, strategic investment, M&A, and exit by shifting focus from execution to how the business is positioned and evaluated.
-
Augmenting capital raise & exit preparation that is grounded in value creation
-
Diligence readiness and de-risking across commercial and operational areas
-
Positioning the business for future growth and strategic transactions
For teams approaching capital or transaction-related inflection points.
Investment Advisory
Advising private equity and venture capital investors with strategic and tactical, board-level judgment applied to investment decisions and portfolio peformance.
-
Commercial and market diligence, from thesis development through deal origination
-
Growth strategy, acquisitions, and portfolio prioritization
-
Ongoing board-level and portfolio company advisory through execution
For investors who value market insight alongside financial and operational analysis.
Thought Leadership & Market Perspective
Providing a clear, current view of how the pharma services market is evolving and what it means for operators and investors. Proven thought leadership in the global, life science ecosystem.
-
Interpreting market shifts across CROs, CDMOs, and life sciences services
-
Shaping industry dialogue through publications, conferences, panels, and media
-
Grounding industry conversations with real-world operating and investment experience
Designed to provide clarity and direction above the noise.
// FEATURED PUBLICATIONS
// OUR SERVICES
How We Create Value
At critical inflection points, we align strategy, capital, and execution to build lasting enterprise value.
Commercial & Market Advisory
Advising leadership teams on translating strong technical capabilities into focused positioning, scalable commercial strategy, and sustainable growth.
-
Commercial leadership support, leveraging strong industry connections
-
Go-to-market & revenue strategy aligned with market demand
-
Market and competitive intelligence to inform positioning & growth decisions
Designed for companies running strong science-led businesses and seeking sharper commercial direction & accelerated revenue growth.
Capital & Transaction Readiness
Enhance value creation by preparing businesses for future capital raises, strategic investment, M&A, and exit; Elevating how the business is viewed by future investors.
-
Capital raise & exit preparation - Grounded in value creation
-
Growth Roadmapping - Positioning for future organic / inorganic growth
-
De-risking across commercial & operational areas
For teams approaching capital or transaction-related inflection points.
Investment Advisory
Advising private equity and venture capital firms with strategic and tactical, board-level judgment applied to investment decisions and portfolio peformance.
-
Board-level and portfolio advisory
-
Deal sourcing and thesis development
-
Commercial and market diligence
-
Growth strategy, add-on acquisitions, and portfolio prioritization
For investors who value deep industry connections and market insight alongside financial & operational analysis.
Thought Leadership & Market Perspective
Providing a clear, current view of how the pharma services market is evolving and what it means for operators and investors.
-
Interpreting market shifts across CROs, CDMOs, and life sciences services
-
Shaping industry dialogue through publications, conferences, panels, and media
-
Grounding industry conversations with real-world operating and investment experience
Designed to provide clarity and direction above the noise.
// WHY FREEDOM
Grounded in Experience, Focused on Value.
Freedom Bioscience Partners brings a market-tested perspective built over decades inside CROs, CDMOs, and PE-backed pharma services businesses. Our work reflects firsthand experience operating at the same inflection points our clients face — when growth accelerates, ownership shifts, and the consequences of decisions begin to compound.
We’ve been in the room for these transitions, helping leaders move with clarity when the stakes rise and the margin for error narrows.
Clients work with Freedom for clarity, judgment, and credibility — Especially when the decisions are complex and the margin for error is small.
Brian Scanlan
Managing Partner
Freedom Bioscience Partners
// WHO WE WORK WITH
Where We Have Built, Advised, & Invested
CROs & CDMOs
Life Science Tools and Materials Companies
Investors in the Pharma Services Market
CROs and CDMOs operating across research, development, and manufacturing within the pharma services ecosystem.
-
Chemical & Biological Process Development
-
Formulation
-
Particle Engineering
-
DS/DP Manufacturing
-
Analytical Services
-
CMC Consulting
-
Bioanalysis
-
Discovery Support
-
Product-oriented businesses providing the critical tools, functional materials, and enabling technologies that underpin drug R&D and manufacturing.
-
Bioprocessing inputs
-
Chemical process inputs
-
Functional excipients
-
In-vitro research tools
-
Tissue models
-
Toxicology tools
-
Synthetic biology platforms
-
Reagents
-
Advanced molecular technologies
-
Venture capital through lower mid-market private equity investors seeking deep sector expertise in pharma services, life science tools and performance materials space.
-
Diligence support
-
Board advisory
-
Thesis development
-
Portfolio strategy
-
Deal Sourcing
Investors engage Freedom for operating judgment, market insight, and access to a highly active industry network.
-
// FEATURED PUBLICATIONS
// FEATURED PUBLICATIONS
Commercial & Market Advisory
Advising leadership teams on translating strong technical capabilities into focused positioning, scalable commercial strategy, and sustainable growth.
-
Commercial leadership support, leveraging strong industry connections
-
Go-to-market & revenue strategy aligned with market demand
-
Market and competitive intelligence to inform positioning and growth decisions
-
Deep network connections to drive strategic partnerships
Designed for small to mid-sized companies running strong science-led businesses and seeking sharper commercial direction & accelerated revenue growth.
Capital & Transaction Readiness
Enhance value creation by preparing businesses for future capital raises, strategic investment, M&A, and exit; Elevating how the business is viewed by future investors.
-
Capital raise & exit preparation - Grounded in value creation
-
Growth Roadmapping - Positioning for future organic / inorganic growth
-
De-risking across commercial & operational areas
For teams approaching capital or transaction-related inflection points.
Investment Advisory
Advising private equity and venture capital firms with strategic and tactical, board-level judgment applied to investment decisions and portfolio peformance.
-
Board-level and portfolio advisory
-
Deal sourcing and thesis development
-
Commercial and market diligence
-
Growth strategy, add-on acquisitions, and portfolio prioritization
For investors who value deep industry connections and market insight alongside financial & operational analysis.
Thought Leadership & Market Perspective
Providing a clear, current view of how the pharma services market is evolving and what it means for operators and investors. Proven thought leadership in the global, life science ecosystem.
-
Interpreting market shifts across CROs, CDMOs, and life sciences services
-
Shaping industry dialogue through publications, conferences, panels, and media
-
Grounding industry conversations with real-world operating and investment experience
Designed to provide clarity and direction above the noise.
// OUR SERVICES
How We Create Value
At critical inflection points, we align strategy, capital, and execution to build lasting enterprise value.
Our work centers across four areas of engagement:
-
Commercial & Market Advisory
-
Capital & Transaction Readiness
-
Investment Advisory
-
Thought Leadership & Market Perspective
Commercial & Market Advisory
Advising leadership teams on translating strong technical capabilities into focused positioning, scalable commercial strategy, and sustainable growth.
-
Commercial leadership support, leveraging strong industry connections
-
Go-to-market & revenue strategy aligned with market demand
-
Market and competitive intelligence to inform positioning and growth decisions
-
Deep network connections to drive strategic partnerships
Designed for small to mid-sized companies running strong science-led businesses and seeking sharper commercial direction & accelerated revenue growth.
Capital & Transaction Readiness
Enhance value creation by preparing businesses for future capital raises, strategic investment, M&A, and exit; Elevating how the business is viewed by future investors.
-
Capital raise & exit preparation - Grounded in value creation
-
Growth Roadmapping - Positioning for future organic / inorganic growth
-
De-risking across commercial & operational areas
For teams approaching capital or transaction-related inflection points.
Investment Advisory
Advising private equity and venture capital firms with strategic and tactical, board-level judgment applied to investment decisions and portfolio peformance.
-
Board-level and portfolio advisory
-
Deal sourcing and thesis development
-
Commercial and market diligence
-
Growth strategy, add-on acquisitions, and portfolio prioritization
For investors who value deep industry connections and market insight alongside financial & operational analysis.
Thought Leadership & Market Perspective
Providing a clear, current view of how the pharma services market is evolving and what it means for operators and investors. Proven thought leadership in the global, life science ecosystem.
-
Interpreting market shifts across CROs, CDMOs, and life sciences services
-
Shaping industry dialogue through publications, conferences, panels, and media
-
Grounding industry conversations with real-world operating and investment experience
Designed to provide clarity and direction above the noise.